The use of signal transducer and activator of transcription 3 (STAT3) antisense oligonucleotides in murine orthotopic pancreatic adenocarcinoma models further validated the therapeutic potential of targeting Tregs. The gene discussed is STAT3; the disease is pancreatic adenocarcinoma.